In addition to our own activities in fund management, we work very closely with other private and public venture funds, new instruments of validation funding, as well as with technology transfer agencies of the key German research foundation and universities. Currently, the most significant areas of collaboration for Peppermint VenturePartners include the Charité – Universitätsmedizin Berlin, the Charité Foundation and Helmholtz Association.

With the establishment of the Helmholtz Validation Fund (HVF) in the year 2011, the Helmholtz Association introduced a new financial instrument across several institutions, tapping funding from the Initiative and Networking Fund. The aim of the HVF is to close the existing gap between research findings and their marketable applications, as well as public research and private institutions. The funding levels from the Helmholtz Validation Fund range between 0.25 and 1 million euros per year. The idea is to evaluate new technologies in terms of their technical feasibility and to achieve a functioning prototype or initial positive pre-clinical validation. In order to ensure professional guidance according to industry and venture capital standards, a network of industry experts and project managers assists the team.

Peppermint VenturePartners has taken over the external fund management as an experienced early-stage investor.